CPHRF - Cipher Pharmaceuticals GAAP EPS of $0.11 revenue of $4.8M November, 10 2022 11:46 PM Companhia Siderurgica Paulista Nova Cosipa Cipher Pharmaceuticals press release ( OTCPK:CPHRF ): Q3 GAAP EPS of $0.11. Revenue of $4.8M (+6.7% Y/Y). For further details see: Cipher Pharmaceuticals GAAP EPS of $0.11, revenue of $4.8M